Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification and Quantification of Novel Major Metabolites of the Steroidal Aromatase Inhibitor, Exemestane.

Luo S, Chen G, Truica CI, Baird CC, Xia Z, Lazarus P.

Drug Metab Dispos. 2018 Sep 26. pii: dmd.118.081166. doi: 10.1124/dmd.118.081166. [Epub ahead of print]

PMID:
30257855
2.

Interest Among Primary Care Patients in Group Problem-Solving Gameplay for Mental Health.

Auer BJ, Sciamanna C, Smyth JM, Truica CI, Cream LV, Mukherjee D.

Prev Chronic Dis. 2018 Jun 21;15:E86. doi: 10.5888/pcd15.170488.

3.

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.

Kornblum N, Zhao F, Manola J, Klein P, Ramaswamy B, Brufsky A, Stella PJ, Burnette B, Telli M, Makower DF, Cheema P, Truica CI, Wolff AC, Soori GS, Haley B, Wassenaar TR, Goldstein LJ, Miller KD, Sparano JA.

J Clin Oncol. 2018 Jun 1;36(16):1556-1563. doi: 10.1200/JCO.2017.76.9331. Epub 2018 Apr 17.

PMID:
29664714
4.

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.

Jia H, Truica CI, Wang B, Wang Y, Ren X, Harvey HA, Song J, Yang JM.

Drug Resist Updat. 2017 May;32:1-15. doi: 10.1016/j.drup.2017.07.002. Epub 2017 Aug 19. Review.

PMID:
29145974
5.

An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.

Felts JL, Zhu J, Han B, Smith SJ, Truica CI.

Breast J. 2017 Nov;23(6):677-686. doi: 10.1111/tbj.12751. Epub 2017 Jan 18.

PMID:
28097781
6.

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.

Matthew EM, Zhou L, Yang Z, Dicker DT, Holder SL, Lim B, Harouaka R, Zheng SY, Drabick JJ, Lamparella NE, Truica CI, El-Deiry WS.

Oncotarget. 2016 Jan 26;7(4):3662-76. doi: 10.18632/oncotarget.6657.

7.

Immunotherapy in Breast Cancer- Paving New Roads?

Truica CI, Cleary AS.

Curr Mol Pharmacol. 2016;9(3):208-216. Review.

PMID:
26177646
8.

Acoustic separation of circulating tumor cells.

Li P, Mao Z, Peng Z, Zhou L, Chen Y, Huang PH, Truica CI, Drabick JJ, El-Deiry WS, Dao M, Suresh S, Huang TJ.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):4970-5. doi: 10.1073/pnas.1504484112. Epub 2015 Apr 6.

9.

Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells.

Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, Belani CP, Truica CI, El-Deiry WS, Allerton JP, Zheng SY.

Clin Chem. 2014 Feb;60(2):323-33. doi: 10.1373/clinchem.2013.206805. Epub 2013 Oct 16.

10.

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.

Gallant JN, Matthew EM, Cheng H, Harouaka R, Lamparella NE, Kunkel M, Yang Z, Harvey HA, Cream LV, Kumar SM, Robertson GP, Zheng S, Drabick JJ, Truica CI, El-Deiry WS.

Cell Cycle. 2013 Jul 1;12(13):2132-43. doi: 10.4161/cc.25165. Epub 2013 Jun 11.

11.

Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.

Gharwan H, Truica CI.

Med Oncol. 2012 Jun;29(2):1197-201. doi: 10.1007/s12032-011-9938-4. Epub 2011 Apr 9.

PMID:
21479696
12.

Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.

Njiaju UO, Truica CI.

Clin Breast Cancer. 2010 Feb;10(1):E3-5. doi: 10.3816/CBC.2010.n.013.

PMID:
20133250
13.

Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.

Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, Jones C, Pietenpol JA.

Clin Cancer Res. 2006 Mar 1;12(5):1570-6.

14.

Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer.

Arteaga CL, Truica CI.

Semin Oncol. 2004 Feb;31(1 Suppl 3):3-8. Review.

PMID:
15052538
16.

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.

Truica CI, Byers S, Gelmann EP.

Cancer Res. 2000 Sep 1;60(17):4709-13.

17.

Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report.

Truica CI, Hansen CH, Garvin DF, Meehan KR.

Cancer. 1998 Sep 15;83(6):1231-6. Erratum in: Cancer 1998 Nov 15;83(10):2239.

PMID:
9740090
18.

Beta-catenin mutations in human prostate cancer.

Voeller HJ, Truica CI, Gelmann EP.

Cancer Res. 1998 Jun 15;58(12):2520-3.

Supplemental Content

Loading ...
Support Center